Paper2432012
Effect of CI-922, a potential new antiallergy agent, on arachidonic acid metabolism in vitro.
Boctor AM and 1 other. Inflammation, 1986. Cited by 4 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Effect of CI-922, a potential new antiallergy agent, on arachidonic acid metabolism in vitro. Papers, record 2432012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2432012
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of CI-922, a potential new antiallergy agent, on arachidonic acid metabolism in vitro.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arachidonic Acids | Major topic |
| Azoles | Major topic |
| Histamine Release | Major topic |
| Indoles | Major topic |
| Leukocytes | Major topic |
| Tetrazoles | Major topic |
| 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine | |
| Adult | |
| Animals | |
| Arachidonate 5-Lipoxygenase | |
| Arachidonic Acid | |
| Calcimycin | |
| Cattle | |
| Humans | |
| Hydroxyeicosatetraenoic Acids | |
| In Vitro Techniques | |
| Indomethacin | |
| Male | |
| Masoprocol | |
| Pyrazoles | |
| Seminal Vesicles |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6,962,465 | Prostaglandin endoperoxide metabolism by microsomes of whole kidneys from normal, congenital unilateral hydronephrotic and unilateral ureteral obstructed rats. | Prostaglandins | 1982 | https://conductscience.org/library/papers/6962465 | PubMed |
| 2 | 6,301,011 | Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. | Science | 1983 | https://conductscience.org/library/papers/6301011 | PubMed |
| 3 | 110,332 | A new approach to anti-inflammatory drugs. | Biochem Pharmacol | 1979 | https://conductscience.org/library/papers/110332 | PubMed |
| 4 | 377,292 | Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/377292 | PubMed |
| 5 | 6,781,575 | The pharmacology of isamoxole [2-methyl-n-butyl-n(4-methyloxazol-2-yl) propanamide] LRCL 3950, a new anti-allergic compound. | Br J Pharmacol | 1980 | https://conductscience.org/library/papers/6781575 | PubMed |
| 6 | 6,221,723 | Differential effects of anti-inflammatory drugs on lipoxygenase and cyclo-oxygenase activities of neutrophils from a reverse passive Arthus reaction. | Biochem Biophys Res Commun | 1983 | https://conductscience.org/library/papers/6221723 | PubMed |
| 7 | 6,171,522 | Control mechanisms of histamine release from human basophils in vitro: the role of phospholipase A2 and of lipoxygenase metabolites. | Int Arch Allergy Appl Immunol | 1981 | https://conductscience.org/library/papers/6171522 | PubMed |
| 8 | 6,417,727 | Inhibition of human neutrophil arachidonate 5-lipoxygenase by 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-prostaglandin I1 (U-60257). | Prostaglandins | 1983 | https://conductscience.org/library/papers/6417727 | PubMed |
| 9 | 382,802 | FPL 55712 -- an antagonist of slow reacting substance of anaphylaxis (SRS-A): a review. | Agents Actions | 1979 | https://conductscience.org/library/papers/382802 | PubMed |
| 10 | 6,405,452 | Selective inhibition of the lipoxygenase metabolic pathway of arachidonic acid by the SRS-A antagonist, FPL 55712. | Prostaglandins | 1983 | https://conductscience.org/library/papers/6405452 | PubMed |
| 11 | 3,020,588 | Meclofenamate sodium is an inhibitor of both the 5-lipoxygenase and cyclooxygenase pathways of the arachidonic acid cascade in vitro. | Prostaglandins Leukot Med | 1986 | https://conductscience.org/library/papers/3020588 | PubMed |
| 12 | 41,912 | Inhibition of rabbit PMN lipoxygenase activity by benoxaprofen. | J Pharm Pharmacol | 1979 | https://conductscience.org/library/papers/41912 | PubMed |
| 13 | 6,191,762 | In vitro inhibition of the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) and lipoxygenase activity by quercetin. | Biochem Pharmacol | 1983 | https://conductscience.org/library/papers/6191762 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ALOX5 | 240 | PubTator's text mining | https://conductscience.org/library/genes/240 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2432012
GET https://conductscience.org/api/papers/v1/2432012/authors